Pathway Capital Management’s Confluent CFLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-41,292
Closed -$1.15M 7
2024
Q4
$1.15M Sell
41,292
-3,743
-8% -$100K 1.15% 7
2024
Q3
$918K Buy
+45,035
New +$1.01M 1.73% 4
2024
Q2
Sell
-56,143
Closed -$1.71M 6
2024
Q1
$1.71M Buy
56,143
+28,615
+104% +$808K 1.6% 9
2023
Q4
$644K Buy
+27,528
New +$665K 0.72% 13

Other funds holding CFLT

Pathway Capital Management's CFLT Position: Q1 2025 in Review

Pathway Capital Management sold out of Confluent (CFLT) in Q1 2025, closing a stake of 41,292 shares — an estimated $1.15M sold.

Pathway Capital Management first reported a position in CFLT in Q4 2023 and held it in 4 quarters. The position peaked at $1.71M in Q1 2024. 400 funds tracked by Wall St. Rank hold CFLT as of Q1 2025.

  • Pathway Capital Management reported no remaining Confluent position as of Q1 2025 after selling out during the quarter.
  • Pathway Capital Management sold 41,292 Confluent shares in Q1 2025, an estimated $1.15M.
  • Pathway Capital Management first reported a position in Confluent in Q4 2023 and held it in 4 quarters.
  • Pathway Capital Management's Confluent position peaked at $1.71M in Q1 2024.
  • 400 funds tracked by Wall St. Rank held Confluent as of Q1 2025.

Based on Pathway Capital Management's 13F filing for Q1 2025, filed 6 May 2025.